社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
云顶新耀(01952)
39.760
+0.900
+2.32%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
公司概况
公司名称
云顶新耀
所属市场
SEHK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.everestmedicines.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
云顶新耀有限公司是一家主要从事创新药及疫苗研发、临床开发、制造及商业化的生物制药公司。该公司已建立跨肾病、抗感染及自身免疫性疾病的产品管线。该公司的产品管线包括用于肾病治疗领域的耐赋康（TARPEYO）、用于治疗包括临床常见的革兰氏阴性菌、革兰氏阳性菌、厌氧菌等多重耐药菌的感染的依嘉（依拉环素）等产品。该公司在国内和国外市场开展业务。
2025-09-04
半年度报告
2025年中期报告
2025年中期报告
2025-08-29
半年度报告
截至2025年6月30日止六个月中期业绩公告
截至2025年6月30日止六个月中期业绩公告
2025-08-01
股份发行
完成根据一般授权配售现有股份及以先旧后新方式认购新股份
完成根据一般授权配售现有股份及以先旧后新方式认购新股份
2025-07-25
股份发行
根据一般授权配售现有股份及以先旧后新方式认购新股份
根据一般授权配售现有股份及以先旧后新方式认购新股份
2025-06-03
股份购回
(1)建议重选董事；(2)建议授出购回股份及发行股份的一般授权；(3)建议重新委任退任核数师；(4)非豁免关连交易 - 建议授予关连人士奖励及表现目标奖励；及(5)股东周年大会通告
(1)建议重选董事；(2)建议授出购回股份及发行股份的一般授权；(3)建议重新委任退任核数师；(4)非豁免关连交易 - 建议授予关连人士奖励及表现目标奖励；及(5)股东周年大会通告
2025-04-24
年度报告
2024年度报告
2024年度报告
2025-04-15
半年度报告
(1)公司秘书变更(2)有关首次公开发售前雇员购股权计划之澄清
(1)公司秘书变更(2)有关首次公开发售前雇员购股权计划之澄清
2025-03-26
年度报告
截至2024年12月31日止年度全年业绩公告
截至2024年12月31日止年度全年业绩公告
2024-09-05
半年度报告
2024年中期报告
2024年中期报告
2024-08-28
半年度报告
截至2024年6月30日止六个月中期业绩公告
截至2024年6月30日止六个月中期业绩公告
2024-06-04
股份购回
(1)建议重选董事；(2)建议授出购回股份及发行股份的一般授权；(3)建议重新委任退任核数师；(4)建议采纳新组织章程大纲及细则；(5)非豁免关连交易 — 建议授予关连人士奖励及表现目标奖励；及(6)股东周年大会通告
(1)建议重选董事；(2)建议授出购回股份及发行股份的一般授权；(3)建议重新委任退任核数师；(4)建议采纳新组织章程大纲及细则；(5)非豁免关连交易 — 建议授予关连人士奖励及表现目标奖励；及(6)股东周年大会通告
2024-04-24
年度报告
2023年度报告
2023年度报告
2024-03-28
年度报告
截至2023年12月31日止年度全年业绩公告
截至2023年12月31日止年度全年业绩公告
2024-02-19
须予披露的交易
有关须予披露交易的更新资料-有关COVID-19疫苗及若干授权产品的制造、开发及商业化的(1)合作及授权许可协议；及(2)股份发行协议
有关须予披露交易的更新资料-有关COVID-19疫苗及若干授权产品的制造、开发及商业化的(1)合作及授权许可协议；及(2)股份发行协议
2023-08-31
半年度报告
2023中期报告
2023中期报告
加载更多
分时
5日
日
周
月
数据加载中...
最高
41.000
今开
38.860
量比
1.74
最低
37.600
昨收
38.860
换手率
1.42%
热议股票
{"pagemeta":{"title":"云顶新耀(01952)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供云顶新耀(01952)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"云顶新耀,01952,云顶新耀股票,云顶新耀股票老虎,云顶新耀股票老虎国际,云顶新耀行情,云顶新耀股票行情,云顶新耀股价,云顶新耀股市,云顶新耀股票价格,云顶新耀股票交易,云顶新耀股票购买,云顶新耀股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"云顶新耀(01952)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供云顶新耀(01952)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"fillings","symbol":"01952","data":{"stockData":{"symbol":"01952","market":"HK","secType":"STK","nameCN":"云顶新耀","latestPrice":39.76,"timestamp":1770365284005,"preClose":38.86,"halted":0,"volume":5039450,"delay":0,"changeRate":0.023160061760164656,"floatShares":354000000,"shares":354000000,"eps":-3.18,"marketStatus":"已收盘","change":0.9,"latestTime":"02-06 16:08:04","open":38.86,"high":41,"low":37.6,"amount":199282800,"amplitude":0.087494,"askPrice":39.76,"askSize":7500,"bidPrice":39.72,"bidSize":6500,"shortable":3,"etf":0,"ttmEps":-2.043,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":5,"adr":0,"listingDate":1602172800000,"exchange":"SEHK","adjPreClose":38.86,"openAndCloseTimeList":[[1770341400000,1770350400000],[1770354000000,1770364800000]],"volumeRatio":1.742564,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"20129278","market":"hk","labels":[],"media":"港交所","original_id":"N.HK6WDCZe3tC1","pdf_url":"https://static.tigerbbs.com/16c57bbdbbe44bfb9e141f804f424a37","pub_time":1756989840000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2025年中期报告","symbol":"01952","title":"2025年中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0904/2025090401962_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-09-04 20:44","pubTimestamp":1756989840,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20097733","market":"hk","labels":[],"media":"港交所","original_id":"N.HK94WNGLLrfX","pdf_url":"https://static.tigerbbs.com/636b423bcb4b4b4293dbc827b556094c","pub_time":1756422000000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2025年6月30日止六个月中期业绩公告","symbol":"01952","title":"截至2025年6月30日止六个月中期业绩公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0829/2025082900182_c.pdf","us_notice_code":"公告及通告 - [中期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-08-29 07:00","pubTimestamp":1756422000,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19937646","market":"hk","labels":[],"media":"港交所","original_id":"N.HK23HFeZLWW5","pdf_url":"https://static.tigerbbs.com/0d63bfe092864a32b5e93b733f3bd1e0","pub_time":1754048040000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"完成根据一般授权配售现有股份及以先旧后新方式认购新股份","symbol":"01952","title":"完成根据一般授权配售现有股份及以先旧后新方式认购新股份","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0801/2025080103474_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-08-01 19:34","pubTimestamp":1754048040,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19909348","market":"hk","labels":[],"media":"港交所","original_id":"N.HKHFWtV2Mzrx","pdf_url":"https://static.tigerbbs.com/1d9e07a8edcf46c2950c57dee683a6d6","pub_time":1753400400000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"根据一般授权配售现有股份及以先旧后新方式认购新股份","symbol":"01952","title":"根据一般授权配售现有股份及以先旧后新方式认购新股份","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0725/2025072500074_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-07-25 07:40","pubTimestamp":1753400400,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19723902","market":"hk","labels":[],"media":"港交所","original_id":"N.HKHGMKpdiMdp","pdf_url":"https://static.tigerbbs.com/6acae0bda8144525950b1fa4c37ebefc","pub_time":1748939820000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"(1)建议重选董事；(2)建议授出购回股份及发行股份的一般授权；(3)建议重新委任退任核数师；(4)非豁免关连交易 - 建议授予关连人士奖励及表现目标奖励；及(5)股东周年大会通告","symbol":"01952","title":"(1)建议重选董事；(2)建议授出购回股份及发行股份的一般授权；(3)建议重新委任退任核数师；(4)非豁免关连交易 - 建议授予关连人士奖励及表现目标奖励；及(5)股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0603/2025060301036_c.pdf","us_notice_code":"通函 - [在股东批准的情况下重选或委任董事 / 一般性授权 / 回购股份的说明函件 / 关连交易 / 股份计划 / 其他]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2025-06-03 16:37","pubTimestamp":1748939820,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19484159","market":"hk","labels":[],"media":"港交所","original_id":"N.HK9HTpt58vsi","pdf_url":"https://static.tigerbbs.com/aae60843c28a49ff811a48c3bc6c7aed","pub_time":1745503200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2024年度报告","symbol":"01952","title":"2024年度报告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0424/2025042403127_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2025-04-24 22:00","pubTimestamp":1745503200,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19395945","market":"hk","labels":[],"media":"港交所","original_id":"N.HK3t2Ep7Bv3e","pdf_url":"https://static.tigerbbs.com/27cf318dbddf42cea15a7f74ac699436","pub_time":1744727520000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"(1)公司秘书变更(2)有关首次公开发售前雇员购股权计划之澄清","symbol":"01952","title":"(1)公司秘书变更(2)有关首次公开发售前雇员购股权计划之澄清","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0415/2025041502044_c.pdf","us_notice_code":"公告及通告 - [更换公司秘书 / 中期业绩 / 股份计划 / 其他-杂项]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-04-15 22:32","pubTimestamp":1744727520,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19283636","market":"hk","labels":[],"media":"港交所","original_id":"N.HKC4KjbtAMsv","pdf_url":"https://static.tigerbbs.com/a7205222261740719fd3d7731216eeb2","pub_time":1742943000000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2024年12月31日止年度全年业绩公告","symbol":"01952","title":"截至2024年12月31日止年度全年业绩公告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0326/2025032600086_c.pdf","us_notice_code":"公告及通告 - [末期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2025-03-26 06:50","pubTimestamp":1742943000,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18583066","market":"hk","labels":[],"media":"港交所","original_id":"N.HKFhFhiLPG72","pdf_url":"https://static.tigerbbs.com/6096fe2fe62d4b08b4732076b6a0027d","pub_time":1725509460000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2024年中期报告","symbol":"01952","title":"2024年中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0905/2024090500452_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2024-09-05 12:11","pubTimestamp":1725509460,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18531572","market":"hk","labels":[],"media":"港交所","original_id":"N.HKHKJ9htT27g","pdf_url":"https://static.tigerbbs.com/ece71ffc246e4b0395dad9bd340f4cb6","pub_time":1724799420000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2024年6月30日止六个月中期业绩公告","symbol":"01952","title":"截至2024年6月30日止六个月中期业绩公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0828/2024082800042_c.pdf","us_notice_code":"公告及通告 - [中期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2024-08-28 06:57","pubTimestamp":1724799420,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18229863","market":"hk","labels":[],"media":"港交所","original_id":"N.HK96rE2k9M1e","pdf_url":"https://static.tigerbbs.com/bda425839ce84f1cb6defad91d380cf5","pub_time":1717491420000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"(1)建议重选董事；(2)建议授出购回股份及发行股份的一般授权；(3)建议重新委任退任核数师；(4)建议采纳新组织章程大纲及细则；(5)非豁免关连交易 — 建议授予关连人士奖励及表现目标奖励；及(6)股东周年大会通告","symbol":"01952","title":"(1)建议重选董事；(2)建议授出购回股份及发行股份的一般授权；(3)建议重新委任退任核数师；(4)建议采纳新组织章程大纲及细则；(5)非豁免关连交易 — 建议授予关连人士奖励及表现目标奖励；及(6)股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0604/2024060401304_c.pdf","us_notice_code":"通函 - [在股东批准的情况下重选或委任董事 / 一般性授权 / 回购股份的说明函件 / 修订宪章文件 / 关连交易 / ...更多]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2024-06-04 16:57","pubTimestamp":1717491420,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"17976681","market":"hk","labels":[],"media":"港交所","original_id":"N.HK8ggoSRLTQg","pdf_url":"https://static.tigerbbs.com/4d2551a8616d4ed68b9f6528a551ffad","pub_time":1713966660000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2023年度报告","symbol":"01952","title":"2023年度报告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0424/2024042402495_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2024-04-24 21:51","pubTimestamp":1713966660,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"17766409","market":"hk","labels":[],"media":"港交所","original_id":"N.HKFAv1wfaD9A","pdf_url":"https://static.tigerbbs.com/4442bd7ee43b4eaebd16da566471fc9a","pub_time":1711579500000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2023年12月31日止年度全年业绩公告","symbol":"01952","title":"截至2023年12月31日止年度全年业绩公告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0328/2024032800190_c.pdf","us_notice_code":"公告及通告 - [末期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2024-03-28 06:45","pubTimestamp":1711579500,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"17609470","market":"hk","labels":[],"media":"港交所","original_id":"N.HKAWq2Qd2S7s","pdf_url":"https://static.tigerbbs.com/f958277a271b4a69ad3c5706bbdb668f","pub_time":1708300200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"有关须予披露交易的更新资料-有关COVID-19疫苗及若干授权产品的制造、开发及商业化的(1)合作及授权许可协议；及(2)股份发行协议","symbol":"01952","title":"有关须予披露交易的更新资料-有关COVID-19疫苗及若干授权产品的制造、开发及商业化的(1)合作及授权许可协议；及(2)股份发行协议","titleType":"须予披露的交易","type":"hkTrade","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0219/2024021900010_c.pdf","us_notice_code":"公告及通告 - [须予披露的交易 / 终止交易 / 其他-业务发展最新情况]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易相关","type_name_en":"Transaction Related","titleTypeEn":"","event_type":"important_notice","event_name":"须予披露的交易","pubTime":"2024-02-19 07:50","pubTimestamp":1708300200,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"16903079","market":"hk","labels":[],"media":"港交所","original_id":"N.HK5FkQSBbK3n","pdf_url":"https://static.tigerbbs.com/a4a3a87a07d74f1c9c00d0c73ec32449","pub_time":1693473240000,"showTitleType":false,"size":0,"source":"hk_ex_news","summary":"2023中期报告","symbol":"01952","title":"2023中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2023/0831/2023083100832_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2023-08-31 17:14","pubTimestamp":1693473240,"notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.everestmedicines.com","stockEarnings":[{"period":"1week","weight":-0.0236},{"period":"1month","weight":-0.027},{"period":"3month","weight":-0.141},{"period":"6month","weight":-0.455},{"period":"1year","weight":-0.0405},{"period":"ytd","weight":0.0508}],"compareEarnings":[{"period":"1week","weight":-0.0387},{"period":"1month","weight":0.0065},{"period":"3month","weight":0.0245},{"period":"6month","weight":0.0815},{"period":"1year","weight":0.3053},{"period":"ytd","weight":0.049}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"云顶新耀有限公司是一家主要从事创新药及疫苗研发、临床开发、制造及商业化的生物制药公司。该公司已建立跨肾病、抗感染及自身免疫性疾病的产品管线。该公司的产品管线包括用于肾病治疗领域的耐赋康（TARPEYO）、用于治疗包括临床常见的革兰氏阴性菌、革兰氏阳性菌、厌氧菌等多重耐药菌的感染的依嘉（依拉环素）等产品。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.01035},{"month":2,"riseRate":0.333333,"avgChangeRate":0.043695},{"month":3,"riseRate":0.4,"avgChangeRate":0.004093},{"month":4,"riseRate":0.2,"avgChangeRate":-0.095155},{"month":5,"riseRate":0.4,"avgChangeRate":-0.02945},{"month":6,"riseRate":0.8,"avgChangeRate":0.307082},{"month":7,"riseRate":0.2,"avgChangeRate":-0.114966},{"month":8,"riseRate":0.2,"avgChangeRate":-0.112869},{"month":9,"riseRate":0.6,"avgChangeRate":0.046163},{"month":10,"riseRate":0.4,"avgChangeRate":-0.024036},{"month":11,"riseRate":0.5,"avgChangeRate":0.086142},{"month":12,"riseRate":0.666667,"avgChangeRate":0.131823}],"exchange":"SEHK","name":"云顶新耀","nameEN":"EVEREST MED"},"aProfile":null}}}